Research

Hormonal

Short-term intensive insulin therapy improves beta-cell function and insulin sensitivity, increasing the likelihood of achieving type 2 diabetes remission compared to oral hypoglycemic agents alone.

For early-stage Type 2 Diabetes, short-term intensive insulin therapy can help restore your pancreas's ability to produce insulin. This approach is more effective for achieving remission than oral medications alone, though it requires strict adherence and monitoring during the intensive phase.

ModerateSupportsMEDIUM confidence
Short-term intensive insulin therapy can improve beta-cell function, increase insulin sensitivity, and reduce hepatic insulin resistance, increasing the chances of achieving T2D remission weeks or months after treatment is ceased compared to treatment with oral hypoglycemic agents alone.
Nicholas Shoung et al. · Scientific Reports · 2025

Why this rating

Based on a systematic mapping of registered trials citing previous meta-analyses, but the paper itself is a mapping study, not a primary clinical trial.

Source

Registered clinical trials targeting type 2 diabetes remission with pharmacological interventions

Nicholas Shoung et al. · Scientific Reports · 2025

DOI 10.1038/s41598-025-00080-9

systematic_reviewCited 3×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →